Financial Times  Nov 15  Comment 
Danish group confident that new product will drive growth
Financial Times  Nov 15  Comment 
ECB order threatens further delays to sale of third-largest lender by assets
Wall Street Journal  Nov 10  Comment 
France’s Sanofi has disappointed investors again with its outlook for diabetes sales, and earnings. Novo Nordisk is better placed but the risks are rising.
FierceBiotech  Nov 5  Comment 
Sanofi signed a deal worth up to $4.2 billion to get its hands on a trio of diabetes treatments from South Korean drugmaker Hanmi Pharmaceutical, filling out its pipeline as it contends with rivals Novo Nordisk and Eli Lilly.
FiercePharma  Nov 4  Comment 
Novo Nordisk CEO Lars Rebien Sørensen speaks of stingy payers and global competition in the world diabetes market, while Sanofi told investors its diabetes drug sales will fall through 2018. But none of this has deterred insulin specialist Novo,...
Motley Fool  Nov 2  Comment 
The joys of reporting in the Danish kroner.

You may also be interested in articles related to Novo Nordisk A/S (NVO):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki